Results 111 to 120 of about 7,915 (181)

How to discontinue potassium iodide in combined therapy with methimazole for initial treatment of Graves' disease. [PDF]

Endocr J
Murakami T, Higaki N, Nishijima Y, Tani J, Noguchi H.   +4 more
europepmc   +1 more source

Delayed Severe Heart Failure Despite Successful Graves' Disease Management. [PDF]

Clin Case Rep
Nakashima H, Kamihara T, Omura T, Shimizu A.   +3 more
europepmc   +1 more source

Use of Carbimazole, Methimazole and Propylthiouracil in Women of Childbearing Age and Exposed Pregnancies in Germany: A Population-Based Study. [PDF]

Drugs Real World Outcomes
Schink T, Frizler M, Kollhorst B, Haug U.   +3 more
europepmc   +1 more source

Severe Liver Dysfunction Within 48 Hours of Thionamide Therapy in Thyrotoxicosis: A Case Report. [PDF]

Am J Case Rep
Annabi C, Noor L, Mullally JA.
europepmc   +1 more source

Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025. [PDF]

Front Endocrinol (Lausanne)
Sun Y, Wang S, Zhou X.
europepmc   +1 more source

Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease.

J Clin Endocrinol Metab
Miyamura K, Ito M, Yamaoka H, Hisakado M, Nishihara E, Fukata S, Nishikawa M, Miyauchi A, Akamizu T.   +8 more
europepmc   +1 more source